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Objective: Site marking is essential to prevent wrong-site surgery, and there are many
skin markers commercially available. However, preoperative skin preparation can erase
thesitemark,especiallywhenachlorhexidineskinpreparationsolutionthatrequiresskin
scrubbing is used. The purpose of our study was to test the hypothesis that some markers
can withstand skin preparation with a chlorhexidine-based skin preparation solution in a
mannersimilartothatofaniodine-basedsolution.Methods:Oneachof5cadavericskin
ﬂaps, we made 2 rows of site markings with 9 types of markers. We then subjected one
row of markings on each ﬂap to a chlorhexidine-based solution and the other row to an
iodine-based solution. A digital photograph was taken before and after each skin prepa-
ration.Usingimagingsoftware,thecontrastingrayscalebetweentheskinandskinmark-
ing was measured on each photograph. The effect of the type of marker and skin prepa-
ration solution on the difference in grayscale contrast was evaluated by multiple linear
regression analysis and signiﬁcant differences were determined (P < .05). Results: In
all cases, the chlorhexidine-based skin preparation solution signiﬁcantly decreased the
contrast measured. No marker was signiﬁcantly better than another. Conclusions: We
conclude that all 9 skin markers are signiﬁcantly erased with the chlorhexidine-based
skin preparation solution. The development of a better skin marker or a chlorhexidine-
based skin preparation solution that does not erase site markings is essential to prevent
wrong-site surgeries and promote patient safety.
Site marking is an essential part of the preoperative process, and surgical associations
currently mandate a time-out to verify the correct surgical site and surgery,1,2 which is
meant to eliminate wrong-site surgery.3−5 The Joint Commission6 recommends that the
site marking be within the surgical ﬁeld after draping and that the time-out be performed
justbeforesurgicalincision.Markingisalsoanessentialpartofsurgicalproceduressuchas
mastopexy,in which the unanesthetizedpatientis marked preoperativelyto provide optimal
cosmesis and symmetry.7 The erasure of such site markings can cause problems in terms
of site identiﬁcation and surgical incision positioning.
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Skin preparation is also part of the preoperative process, and chlorhexidine-based skin
preparation solutions have been recommended as a way of decreasing the risk of postoper-
ative wound infection.8,9 However, at least 1 commercially available chlorhexidine-based
skin preparation solution (Chloraprep; chlorhexidine gluconate, 2% w/v, plus isopropyl
alcohol, 70% v/v; Enturia, Inc, Leawood, Kan), which requires a surgical scrub application
for 30 seconds, has been found to erase site marking when made with 1 type of marking
pen.10 Although several other skin-marking pens (some disposable) are now available in
different sizes and ink colors, to our knowledge, no study has assessed their ability to
withstand such skin preparation.
Therefore, the purpose of this study was to test the hypothesis that some markers
can withstand skin preparation with a chlorhexidine-based skin preparation solution in a
manner similar to that with an iodine-based solution.
METHODS
Five ﬂaps of skin from male white cadavers were obtained from the State Anatomy Board.
The skin ﬂaps were warmed to 20◦C, and the temperature was measured with a thermo-
couple (K-type; Omega Engineering, Inc, Stamford, Conn). Nine commercially available
pens speciﬁcally marketed for skin marking were identiﬁed through an Internet search. On
each ﬂap of skin, 2 separate rows of marks were made with each of the 9 types of pens:
(1) Sandel 4-in-1 marker (skin, wide) (Sandel Medical Industries, LLC, Chatsworth, Calif);
(2) Waterproof Permanent Marker-Mini, Fine Tip (Viscot Medical LLC, East Hanover,
NJ); (3) OP-marks mini markers (OP-marks, Inc, Bogart, Ga); (4) OP-marks mini max
(OP-marks, Inc); (5) Accu-line wide body (Accu-line Products, Inc, Hyannis, Mass);
(6) Sharpie super permanent marker (Sanford Corporation, Oak Brook, Ill); (7) Securline
surgical skin marker no. 1000 (Precision Dynamics Corporation, San Fernando, Calif);
(8) HMS Twin-Tip broad (Hospital Marketing Services Co, Inc, Naugatuck, Conn);
and (9) HMS Twin-Tip ﬁne (Hospital Marketing Services Co, Inc). Each mark was a
single vertical line that was approximately 50 mm long. Digital photographs (Fig 1) were
obtainedwitha10.1-megapixelcamera(DigitalRebelXTi;CanonUSA,Inc,LakeSuccess,
NY), equipped with a 100-mm macro lens (EF 100-mm f /2.8 USM Macro Lens; Canon
USA, Inc) and a ring ﬂash (MR-14EX TTL; Canon USA, Inc). Camera settings included a
shutter speed of 1/60 seconds and an F-stop value of 4.0.
The markings were allowed to dry for at least 15 minutes before skin preparation.
On each skin ﬂap, a chlorhexidine-based skin preparation solution (Chloraprep) was ap-
plied to one row of markings and an iodine-based skin preparation solution (Duraprep;
iodophor, 0.7% available iodine, plus isopropyl alcohol, 74% w/w; 3M Healthcare, St Paul,
Minn), which served as the control, was applied to the other row. Both solutions were
applied according to their respective manufacturer’s guidelines. Chloraprep was applied for
30 seconds, with repeated forward and backward strokes of the applicator. Duraprep was
applied by painting a single layer of the solution on the site. No scrubbing motion was used
during Duraprep application. The surface of the skin ﬂaps was allowed to dry completely
after skin preparation and then we obtained a second set of digital images with the same
camera and settings.
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Figure 1. Photographs of skin markings before (left) and after (right) the application of a
chlorhexidine-based (top) or iodine-based (bottom) skin preparation solution. Marks made with
each of the pens from left to right are as follows: Sandel 4-in-1 marker, Waterproof Permanent
Marker-Mini, OP-marks mini markers, OP-marks mini max, Accu-line wide body, Sharpie su-
per permanent marker, Securline surgical skin marker no. 1000, HMS Twin-Tip broad, and HMS
Twin-Tip ﬁne.
Adobe Photoshop CS2 (Adobe Systems, Inc, San Jose, Calif) was used to convert the
raw digital images into a grayscale with 256 levels (with 0 being the darkest and 255 being
white). The mean contrast in grayscale between each mark and its surrounding skin was
determined with the program’s histogram tool. The difference between grayscale contrast
measurements of the images before and after skin preparation was calculated.
The effect of the type of marker and skin preparation solution on the difference in
grayscale contrast was evaluated by multiple linear regression analysis (Stata10; Stata-
Corp, LP, College Station, Tex). Unless otherwise speciﬁed, differences were considered
signiﬁcant at P < .05.
RESULTS
The mean grayscale contrast for all markings with Chloraprep application was signiﬁcantly
lower than that of the preapplication marking (Table 1). Duraprep application did not
signiﬁcantly alter the mean grayscale contrast for any of the surgical markers (Table 1).
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There were no signiﬁcant differences between markings subjected to Chloraprep, that is,
none of the markings resisted erasure signiﬁcantly better than another.
Table 1. Mean differences in grayscale contrast by skin preparation
Mean (95% conﬁdence interval)
difference
Type of pen Chloraprep Duraprep
Sandel 4-in-1 marker (skin, wide) 40.5 (28.8–52.1) 4.4 (−10.9 to 19.6)
Waterproof Permanent Marker-Mini, Fine Tip 47.8 (37.5–58.1) 3.9 (−2.2 to 10.0)
OP-marks mini markers 47.9 (39.2–56.7) 3.7 (−0.5 to 7.9)
OP-marks mini max 49.4 (39.5–59.4) 3.9 (−4.2 to 12.0)
Accu-line wide body 51.2 (45.0–57.3) 9.9 (7.1–12.6)
Sharpie super permanent marker 53.5 (44.5–62.4) 9 (−2.8 to 21.6)
Securline surgical skin marker no. 1000 36.0 (28.6–43.4) 12.3 (3.6–21.1)
HMS Twin-Tip broad 40.2 (33.5–47.0) 2.4 (0.0–4.8)
HMS Twin-Tip ﬁne 26.2 (16.2–36.2) 2.4 (−4.2 to 8.9)
DISCUSSION
Results of our study suggest that currently available skin markers are signiﬁcantly erased
when chlorhexidine-based skin preparation solution is used to prepare the skin, thus re-
jecting our hypothesis that there was a marker compatible with chlorhexidine-based skin
preparation solution. We found no marker less vulnerable to erasure than another when
exposed to the chlorhexidine-based skin preparation solution.
However, site-marking erasure might be prevented through various mechanisms.
Marker technology could evolve so that the ink is more permanent and cannot be erased
with skin preparation. The type of chlorhexidine preparation solution could be changed so
that it does not erase the marks. It is possible that the recommended application method
could be altered to lessen site-marking erasure. Currently, the chlorhexidine-based skin
preparation solution is applied by a scrubbing technique because this is the method of ap-
plicationapprovedbytheUSFoodandDrugAdministrationforthisproduct.Thescrubbing
action, however, may exacerbate the erasure of the markings. Changing the skin prepara-
tion process would require US Food and Drug Administration approval and veriﬁcation of
effectiveness in skin decontamination.
The exact protocol of the time-out process could also be changed. We used the def-
inition of the time-out process supplied by The Joint Commission Universal Protocol.6
With this method, the site marking must be visible in the prepared and draped surgical
ﬁeld immediately before skin incision. The time-out is then the ﬁnal check before surgical
incision.3 This strict deﬁnition is necessary to eliminate wrong-site surgery. Although it
has been common practice to perform the time-out before positioning or skin preparation,
doing so may introduce the opportunity for wrong-site surgery.
Limitationsofthisstudyincludetheuseofcadavericinsteadofliveskin.Itisunknown
whether the 2 types of skin respond differently to marker ink. A randomized prospective
study (ClinicalTrials.gov Identiﬁer: NCT00739583) is currently underway to investigate
the durability of surgical-site markings when exposed to skin preparation solutions. All
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specimens in the current study had light skin coloration (white). We expect to include skin
with darker pigmentation, which may reduce the contrast of the ink and make site-marking
visibility even more challenging. The threshold for marking erasure is also unknown. The
surgeon subjectively determines the degree to which a surgical mark is not visible. Our
position is the same as that of The Joint Commission; namely, that the marker used should
make site markings sufﬁciently permanent to remain visible after completion of the skin
preparation and sterile draping.6
In conclusion, we did not ﬁnd any skin marker that withstood the effects of the
chlorhexidine-based skin preparation solution. The grayscale contrast was signiﬁcantly
decreased for all types of markers after the application of Chloraprep. Additional effort is
needed to ensure that surgical-site markings are retained when a chlorhexidine-based skin
preparation solution is used.
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